Filing
Spy
Filing
Spy
Home
About
HALO
Halozyme Therapeutics Inc
0.25% Convertible Senior Notes due 2027
CUSIP: 40637H109
Healthcare
US
2 holders
Ownership
Activity
2025 Q3
2 of 25 quarters
Total Value
$36.02M
Total Shares
491.2K
Net Share Change
+491.2K
Activity
2 buying
Investor
Value
Shares
Weight
Change
Bridgewater Associates LP
$35.72M
487.1K
0.1%
NEW
Bridgewater Associates LP
$35.72M
487.1K shares
NEW
Pzena Investment Management
$301.2K
4.1K
0.0%
NEW
Pzena Investment Management
$301.2K
4.1K shares
NEW
HALO — Halozyme Therapeutics Inc - FilingSpy